Início › Câncer (todos os tipos) › Califórnia
Ensaios clínicos de Câncer (todos os tipos) em Califórnia
175 estudos para Câncer (todos os tipos) estão buscando participantes em locais em Califórnia.
Cidades em Califórnia
- Los Angeles73 estudos
- Mountain View40 estudos
- San Francisco35 estudos
- Baldwin Park33 estudos
- San Diego32 estudos
- Santa Monica21 estudos
- Irvine16 estudos
- Orange13 estudos
- Santa Rosa11 estudos
- Sacramento11 estudos
- Santa Barbara7 estudos
- Concord7 estudos
- Huntington Beach6 estudos
- Newport Beach6 estudos
- San Jose6 estudos
- Long Beach6 estudos
- Fullerton5 estudos
- Glendale5 estudos
- Vallejo5 estudos
- Oakland5 estudos
- Roseville4 estudos
- Richmond4 estudos
- Fresno4 estudos
- Sunnyvale3 estudos
- Modesto3 estudos
- Mission Viejo3 estudos
- Bakersfield3 estudos
- Pleasanton3 estudos
- Santa Clara3 estudos
Texto oficial do estudo (Inglês)
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, La Jolla
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06796907Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- e mais 10
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- City of Hope Duarte, Duarte
- University of California at Los Angeles, Santa Monica
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07529808A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Start Los Angeles /ID# 281533, Los Angeles
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 1 de out. de 2026 · NCT07024784A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 277005, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07155187A Study of ASP3082 in Adults With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- UCLA Santa Monica Hematology Oncology, Santa Monica
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT05382559A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07192471Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07566156A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- City of Hope National Medical Center /ID# 280273, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07409246A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07744126uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Providence St. Johns Health Center, Santa Monica
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05874921Registry Study for Radiation Therapy Outcomes
- California Protons Cancer Therapy Center, San Diego
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT01255748A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Los Angeles
- PHN-012-001 Site, San Diego
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- City of Hope Comprehensive Cancer Center, Duarte
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06884618A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Sansum Clinic, Santa Barbara
RecrutandoFase 3
Idades de 18 a 100 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05920356Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04981119A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- e mais 14
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06989437A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Children's Hospital Los Angeles ( Site 4006), Los Angeles
RecrutandoFase 1/2
1 Month – 17 Years · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07630974A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- City of Hope, Duarte
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06150157A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- CBCC Global Research - Comprehensive Blood & Cancer Center, Bakersfield
- TOI Clinical Research, Cerritos
- University of California, San Diego Moores Cancer Center, La Jolla
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 1, Duarte
- Quetzal Site 7, Los Angeles
- Quetzal Site 5, Stanford
RecrutandoFase 3
Idades de 18 a 71 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07504458Intratumoral N17350 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
- Scripps Clinic Torrey Pines - La Jolla, San Diego
- e mais 1
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07339176A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 281322, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07365241A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- City of Hope /ID# 243157, Duarte
- City Of Hope - Seacliff /ID# 263143, Huntington Beach
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04928846Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Sutter Auburn, Auburn
- Sutter Alta Bates, Berkeley
- The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
- e mais 19
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT02693535Prospective Study to Assess a Diagnostic Aid for Cancer
- Southern California Research Center, Coronado
- Palomar Health, Poway
- South Coast Gynecologic Oncology, San Diego
RecrutandoEstudo observacional
Idades 45 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- City Of Hope, Duarte
- University Of California San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco- California, San Francisco
- e mais 2
RecrutandoFase 2/3
Todas as idades · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Childrens Hospital Los Angeles ( Site 3006), Los Angeles
RecrutandoFase 1/2
1 Month – 17 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06941272Statins to Prevent Cancer Associated Blood Clots
- City of Hope, Irvine
RecrutandoFase 4
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07303816RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07002034Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- University of California, San Francisco, San Francisco
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06633224(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04996875A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Southern California /ID# 272414, Los Angeles
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06953960Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
- UC Davis Health, Sacramento
- UC Davis Medical Center, Sacramento
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06722508A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT05123482A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- University of Southern California Norris Comprehensive, Los Angeles
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06634589Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- UCI Health Chao Family Comprehensive Cancer Center, Orange
- Investigational Site Number: 403, Palo Alto
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05997615A Phase 1/1b Study of IAM1363 in HER2 Cancers
- UCSD Moores Cancer Center, La Jolla
- USC Norris Comprehensive Cancer Center, Los Angeles
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06253871Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
- Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale
Recrutando
Idades 70 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07629206Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.